Yotnda P - Search Results

1

Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.

Thammanichanond D, Moneer S, Yotnda P, Aitken C, Earnest-Silveira L, Jackson D, Hellard M, McCluskey J, Torresi J, Bharadwaj M. Thammanichanond D, et al. Among authors: yotnda p. Clin Immunol. 2008 Sep;128(3):329-39. doi: 10.1016/j.clim.2008.04.002. Epub 2008 Jun 3. Clin Immunol. 2008. PMID: 18524682

2

Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine.

Duraiswamy J, Bharadwaj M, Tellam J, Connolly G, Cooper L, Moss D, Thomson S, Yotnda P, Khanna R. Duraiswamy J, et al. Among authors: yotnda p. Cancer Res. 2004 Feb 15;64(4):1483-9. doi: 10.1158/0008-5472.can-03-2196. Cancer Res. 2004. PMID: 14973049

3

Targeted delivery of adenoviral vectors by cytotoxic T cells.

Yotnda P, Savoldo B, Charlet-Berguerand N, Rooney C, Brenner M. Yotnda P, et al. Blood. 2004 Oct 15;104(8):2272-80. doi: 10.1182/blood-2003-11-3803. Epub 2004 May 25. Blood. 2004. PMID: 15161664 Free article.

4

Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40(+) and CD40(-) plasmacytoma cells.

Dotti G, Savoldo B, Yotnda P, Rill D, Brenner MK. Dotti G, et al. Among authors: yotnda p. Blood. 2002 Jul 1;100(1):200-7. doi: 10.1182/blood.v100.1.200. Blood. 2002. PMID: 12070028 Free article.

5

An inducible caspase 9 safety switch for T-cell therapy.

Straathof KC, Pulè MA, Yotnda P, Dotti G, Vanin EF, Brenner MK, Heslop HE, Spencer DM, Rooney CM. Straathof KC, et al. Among authors: yotnda p. Blood. 2005 Jun 1;105(11):4247-54. doi: 10.1182/blood-2004-11-4564. Epub 2005 Feb 22. Blood. 2005. PMID: 15728125 Free PMC article.

6

Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses.

Yotnda P, Chen DH, Chiu W, Piedra PA, Davis A, Templeton NS, Brenner MK. Yotnda P, et al. Mol Ther. 2002 Mar;5(3):233-41. doi: 10.1006/mthe.2002.0545. Mol Ther. 2002. PMID: 11863412 Free article.

7

Liposomal enhancement of the antitumor activity of conditionally replication-competent adenoviral plasmids.

Yotnda P, Davis AR, Hicks MJ, Templeton NS, Brenner MK. Yotnda P, et al. Mol Ther. 2004 Apr;9(4):489-95. doi: 10.1016/j.ymthe.2004.01.018. Mol Ther. 2004. PMID: 15093179 Free article.

8

Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment.

Kim H, Peng G, Hicks JM, Weiss HL, Van Meir EG, Brenner MK, Yotnda P. Kim H, et al. Among authors: yotnda p. Mol Ther. 2008 Mar;16(3):599-606. doi: 10.1038/sj.mt.6300391. Epub 2008 Jan 29. Mol Ther. 2008. PMID: 18227840 Free article.

9

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

Yotnda P, Onishi H, Heslop HE, Shayakhmetov D, Lieber A, Brenner M, Davis A. Yotnda P, et al. Gene Ther. 2001 Jun;8(12):930-7. doi: 10.1038/sj.gt.3301488. Gene Ther. 2001. PMID: 11426333

10

Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.

Takahashi S, Rousseau RF, Yotnda P, Mei Z, Dotti G, Rill D, Hurwitz R, Marini F, Andreeff M, Brenner MK. Takahashi S, et al. Among authors: yotnda p. Hum Gene Ther. 2001 Apr 10;12(6):659-70. doi: 10.1089/104303401300057360. Hum Gene Ther. 2001. PMID: 11426465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters